Senti Biosciences Holdings (SNTI) Shares Outstanding (2021 - 2025)
Senti Biosciences Holdings (SNTI) recorded quarterly Shares Outstanding of $30.9 million in Q4 2025, up 17.45% quarter-over-quarter from $26.3 million in Q3 2025, and up 539.45% on a YoY basis from $4.8 million in Q4 2024.
Senti Biosciences Holdings (SNTI) Shares Outstanding (2021 - 2025) Analysis & Trends
Senti Biosciences Holdings' Shares Outstanding history runs 5 years deep, the most recent figure standing at $30.9 million for Q4 2025.
- In Q4 2025, Shares Outstanding rose 539.45% year-over-year to $30.9 million; the TTM figure through Dec 2025 stood at $30.9 million (up 539.45% YoY), while the FY2025 annual figure was $30.9 million, up 539.45% from the prior year.
- Shares Outstanding was $30.9 million for Q4 2025 at Senti Biosciences Holdings, up from $26.3 million in the prior quarter.
- In the past five years, Shares Outstanding ranged from a high of $43.6 million in Q3 2022 to a low of $2.9 million in Q1 2021.
- Historically, Shares Outstanding has averaged $12.6 million across 5 years, with a median of $4.6 million in 2023.
- The sharpest annual moves came in 2022 and 2023: Shares Outstanding jumped 1387.68% in 2022, then plunged 89.81% in 2023.
- A 5-year view of Shares Outstanding shows it stood at $3.0 million in 2021, then jumped by 48.23% to $4.4 million in 2022, then climbed by 3.72% to $4.6 million in 2023, then rose by 5.67% to $4.8 million in 2024, then soared by 539.45% to $30.9 million in 2025.
- The last three Shares Outstanding figures came in at $30.9 million (Q4 2025), $26.3 million (Q3 2025), and $26.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | 400.00 Bn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 91.57 Bn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 254.16 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Senti Biosciences Holdings | 21.76 Mn | 21.76 Mn | - | 30.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 30.88 Mn |
| Dec 31, 2025 | 30.88 Mn |
| Dec 31, 2025 | 30.88 Mn |
| Dec 31, 2025 | 30.88 Mn |
| Dec 31, 2025 | 30.88 Mn |
| Dec 31, 2025 | 30.88 Mn |
| Dec 31, 2025 | 30.88 Mn |
| Dec 31, 2025 | 30.88 Mn |
| Sep 30, 2025 | 26.29 Mn |
| Sep 30, 2025 | 26.29 Mn |
| Sep 30, 2025 | 26.29 Mn |
| Sep 30, 2025 | 26.29 Mn |
| Sep 30, 2025 | 26.29 Mn |
| Sep 30, 2025 | 26.29 Mn |
| Sep 30, 2025 | 26.29 Mn |
| Sep 30, 2025 | 26.29 Mn |
| Jun 30, 2025 | 26.16 Mn |
| Jun 30, 2025 | 26.16 Mn |
| Jun 30, 2025 | 26.16 Mn |
| Jun 30, 2025 | 26.16 Mn |